[1] |
Aggarwal VK,Rasouli MR,Parvizi J. Periprosthetic joint infection:Current concept[J]. Indian J Orthop, 2013, 47(1): 10-17.
|
[2] |
Clohisy JC,Calvert G,Tull F, et al. Reasons for revision hip surgery: a retrospective review[J]. Clin Orthop Relat Res, 2004, (429): 188-192.
|
[3] |
Elgeidi A,Elganainy AE,Abou Elkhier N, et al. Interleukin-6 and other inflammatory markers in diagnosis of periprosthetic joint infection[J]. Int Orthop, 2014, 38(12): 2591-2595.
|
[4] |
Xie K,Qu XH,Yan MN. Procalcitonin and alpha-defensin for diagnosis of periprosthetic joint infections[J]. J Arthroplasty, 2017, 32(4): 1387-1394.
|
[5] |
Yuan K,Chen HL,Cui ZM. Diagnostic accuracy of C-Reactive protein for periprosthetic joint infection: a meta-analysis[J]. Surg Infect (Larchmt), 2014, 15(5): 548-559.
|
[6] |
Parvizi J,Zmistowski B,Berbari EF, et al. New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society[J]. Clin Orthop Relat Res, 2011, 469(11): 2992-2994.
|
[7] |
Berend KR,Lombardi AV,Morris MJ, et al. Two-stage treatment of hip periprosthetic joint infection is associated with a high rate of infection control but high mortality[J]. Clin Orthop Relat Res, 2013, 471(2): 510-518.
|
[8] |
Kurtz S,Ong K,Lau E, et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030[J]. J Bone Joint Surg Am, 2007, 89(4): 780-785.
|
[9] |
Parvizi J,Adeli B,Zmistowski B, et al. Management of periprosthetic joint infection: the current knowledge: AAOS exhibit selection[J/OL]. J Bone Joint Surg Am, 2012, 94(14): e104. doi: 10.2106/JBJS.K.01417.
|
[10] |
White J,Kelly M,Dunsmuir R. C-reactive protein level after total hip and total knee replacement[J]. J Bone Joint Surg Br, 1998, 80(5): 909-911.
|
[11] |
Almeida Herrero F,López Lozano R,Silvestre Muñoz A. Descriptive analysis of C-Reactive values after uncomplicated total hip and knee arthroplasty[J]. Acta Ortop Mex, 2008, 22(2): 80-84.
|
[12] |
Kim TW,Kim DH,Oh WS, et al. Analysis of the causes of elevated C-reactive protein level in the early postoperative period after primary total knee arthroplasty[J]. J Arthroplasty, 2016, 31(9): 1990-1996.
|
[13] |
Mcarthur BA,Abdel MP,Taunton MJ, et al. Seronegative infections in hip and knee arthroplasty: periprosthetic infections with normal erythrocyte sedimentation rate and C-reactive protein level[J]. Bone Joint J, 2015, 97-B(7): 939-944.
|
[14] |
Steg PG,Ravaud P,Tedgui A, et al. Predischarge C-reactive protein and 1-year outcome after acute coronary syndromes[J]. Am J Med, 2006, 119(8): 684-692.
|
[15] |
Dupont C,Rodenbach J,Flachaire E. The value of C-reactive protein for postoperative monitoring of lower limb arthroplasty[J]. Ann Readapt Med Phys, 2008, 51(5): 348-357.
|
[16] |
Codine P,Barbotte E,Denis-Laroque F, et al. C-reactive protein,leukocyte count and D-dimer monitoring after orthopedic surgery: early diagnosis of infectious or thromboembolic complications. Part one: C-reactive protein and leukocyte count as an aid in diagnosing postoperative infection[J]. Ann Readapt Med Phys, 2005, 48(8): 590-597.
|
[17] |
Ishii Y,Noguchi H,Takeda M, et al. Characteristics and significance of fever during 4 weeks after primary total knee arthroplasty[J]. Arch Orthop Trauma Surg, 2014, 134(5): 707-712.
|
[18] |
刘晓东.术前ESR,CRP升高患者行人工关节置换术后风险分析[D].济南:山东中医药大学,2006.
|
[19] |
Jämsen E,Nevalainen P,Eskelinen A, et al. Obesity, diabetes, and preoperative hyperglycemia as predictors of periprosthetic joint infection: a single-center analysis of 7181 primary hip and knee replacements for osteoarthritis[J/OL]. J Bone Joint Surg Am, 2012, 94(14): e101. doi: 10.2106/JBJS.J.01935.
|
[20] |
Poultsides LA,Ma Y,Della Valle AG, et al. In-hospital surgical site infections after primary hip and knee arthroplasty-incidence and risk factors[J]. J Arthroplasty, 2013, 28(3): 385-389.
|